Haemonetics | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Avanos Medical USD 598.1M 439.7M 2024-12
Baxter International USD 3.19B 644M 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Boston Scientific USD 3.89B 410M 2024-12
Cooper Companies USD 782.7M 37.3M 2025-01
Fresenius EUR 5.16B 287M 2024-12
Fresenius Medical Care EUR 4.83B 528.89M 2024-12
Globus Medical USD 597.02M 19.41M 2024-12
Haemonetics USD 289.51M 4.3M 2024-12
Hologic USD 792M 34M 2024-12
ICU Medical USD 592.11M 11.22M 2024-12
Intuitive Surgical USD 1.68B 882M 2024-12
Masimo USD 959.8M 485.3M 2024-12
Medtronic USD 6.65B 162M 2025-01
Merit Medical Systems USD 318.59M 16.01M 2024-12
Neogen USD 688.74M 474.04M 2024-11
Quidel USD 808.2M 96.1M 2024-12
ResMed USD 864.85M 27.65M 2024-12
STAAR Surgical USD 76.86M 6.05M 2024-12
Steris USD 1.13B 9.69M 2024-12
Stryker USD 5.86B 1.45B 2024-12
Teleflex USD 905.79M 290.73M 2024-12
Terumo JPY 217.77B 10.36B 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
US Physical Therapy USD 165.91M 12.62M 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12



Haemonetics Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.